Edition:
United Kingdom

Sonoma Pharmaceuticals Inc (SNOA.OQ)

SNOA.OQ on NASDAQ Stock Exchange Capital Market

1.88USD
15 Aug 2018
Change (% chg)

$-0.13 (-6.47%)
Prev Close
$2.01
Open
$2.01
Day's High
$2.02
Day's Low
$1.80
Volume
12,431
Avg. Vol
13,090
52-wk High
$5.92
52-wk Low
$1.57

Chart for

About

Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and markets solutions for management of dermatological conditions and advanced tissue care. The Company's product portfolio consists of dermatology, animal health, and advanced tissue care products based upon its Microcyn technology. Its Microcyn... (more)

Overall

Beta: 1.23
Market Cap(Mil.): $22.06
Shares Outstanding(Mil.): 4.31
Dividend: --
Yield (%): --

Financials

  SNOA.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -2.11 -- --
ROI: -66.04 15.07 14.61
ROE: -68.22 16.59 16.33

BRIEF-Sonoma Pharma Receives Four New Uae Regulatory Approvals That Include Acne And Anti-Fungal Products

* SONOMA PHARMACEUTICALS RECEIVES FOUR NEW UAE REGULATORY APPROVALS THAT INCLUDE ACNE AND ANTI-FUNGAL PRODUCTS

17 Apr 2018

BRIEF-Sonoma Pharmaceuticals Announces FDA Approval For Antimicrobial Post Therapy Gel

* ANNOUNCES FDA APPROVAL FOR ANTIMICROBIAL POST THERAPY GEL Source text for Eikon: Further company coverage:

05 Apr 2018

BRIEF-Montreux Equity Partners Reports 9.26 Pct Passive Stake In Sonoma Pharmaceuticals

* MONTREUX EQUITY PARTNERS REPORTS 9.26 PERCENT PASSIVE STAKE IN SONOMA PHARMACEUTICALS AS OF MARCH 2 - SEC FILING Source text: (http://bit.ly/2FvWSFR) Further company coverage:

09 Mar 2018

BRIEF-Sonoma Pharmaceuticals Closes $5 Million Public Offering

* SONOMA PHARMACEUTICALS ANNOUNCES CLOSING OF $5 MILLION PUBLIC OFFERING OF COMMON STOCK

07 Mar 2018

BRIEF-Sonoma Pharmaceuticals Announces Pricing Of $5 Mln Public Offering Of Common Stock

* SONOMA PHARMACEUTICALS ANNOUNCES PRICING OF $5 MILLION PUBLIC OFFERING OF COMMON STOCK

02 Mar 2018

Earnings vs. Estimates